1. Home
  2. TLSA vs LEGT Comparison

TLSA vs LEGT Comparison

Compare TLSA & LEGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSA
  • LEGT
  • Stock Information
  • Founded
  • TLSA 2013
  • LEGT 2023
  • Country
  • TLSA United Kingdom
  • LEGT United States
  • Employees
  • TLSA N/A
  • LEGT N/A
  • Industry
  • TLSA Biotechnology: Pharmaceutical Preparations
  • LEGT
  • Sector
  • TLSA Health Care
  • LEGT
  • Exchange
  • TLSA Nasdaq
  • LEGT Nasdaq
  • Market Cap
  • TLSA 240.0M
  • LEGT 279.4M
  • IPO Year
  • TLSA 2000
  • LEGT 2024
  • Fundamental
  • Price
  • TLSA $1.94
  • LEGT $10.89
  • Analyst Decision
  • TLSA
  • LEGT
  • Analyst Count
  • TLSA 0
  • LEGT 0
  • Target Price
  • TLSA N/A
  • LEGT N/A
  • AVG Volume (30 Days)
  • TLSA 336.7K
  • LEGT 4.6K
  • Earning Date
  • TLSA 05-06-2025
  • LEGT 01-01-0001
  • Dividend Yield
  • TLSA N/A
  • LEGT N/A
  • EPS Growth
  • TLSA N/A
  • LEGT N/A
  • EPS
  • TLSA N/A
  • LEGT 0.33
  • Revenue
  • TLSA N/A
  • LEGT N/A
  • Revenue This Year
  • TLSA N/A
  • LEGT N/A
  • Revenue Next Year
  • TLSA N/A
  • LEGT N/A
  • P/E Ratio
  • TLSA N/A
  • LEGT $33.12
  • Revenue Growth
  • TLSA N/A
  • LEGT N/A
  • 52 Week Low
  • TLSA $0.63
  • LEGT $10.22
  • 52 Week High
  • TLSA $2.60
  • LEGT $10.95
  • Technical
  • Relative Strength Index (RSI)
  • TLSA 47.55
  • LEGT 64.68
  • Support Level
  • TLSA $1.81
  • LEGT $10.79
  • Resistance Level
  • TLSA $2.04
  • LEGT $10.95
  • Average True Range (ATR)
  • TLSA 0.18
  • LEGT 0.04
  • MACD
  • TLSA -0.03
  • LEGT 0.01
  • Stochastic Oscillator
  • TLSA 25.00
  • LEGT 71.43

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

About LEGT Legato Merger Corp. III

Legato Merger Corp III is a blank check company.

Share on Social Networks: